Company page

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker CAPR. The company focuses on developing innovative therapies for various diseases, with a market capitalization of approximately $1.49 billion. Capricor is dedicated to advancing its research and product pipeline to address unmet medical needs.